Electromed, Inc. (ELMD) DCF Valuation

Valoración de DCF de Electromed, Inc. (ELMD)

US | Healthcare | Medical - Devices | AMEX
Electromed, Inc. (ELMD) DCF Valuation
  • Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • Predeterminadas Para Un Uso Rápido Y Eficiente
  • No Se Necesita Experiencia; Fáciles De Seguir

Electromed, Inc. (ELMD) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore su estrategia de inversión con la calculadora DCF de Electromed, Inc. (ELMD)! Explore datos financieros auténticos, ajuste las predicciones y gastos de crecimiento, e inmediatamente observe cómo estos cambios afectan el valor intrínseco de Electromed.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 32.5 35.8 41.7 48.1 54.7 62.4 71.1 81.0 92.3 105.2
Revenue Growth, % 0 10.12 16.51 15.38 13.83 13.96 13.96 13.96 13.96 13.96
EBITDA 5.9 3.8 3.6 4.6 7.4 7.5 8.6 9.8 11.1 12.7
EBITDA, % 18.04 10.49 8.64 9.61 13.56 12.07 12.07 12.07 12.07 12.07
Depreciation .7 .6 .6 .6 .8 1.0 1.2 1.3 1.5 1.7
Depreciation, % 2.27 1.71 1.51 1.28 1.54 1.66 1.66 1.66 1.66 1.66
EBIT 5.1 3.1 3.0 4.0 6.6 6.5 7.4 8.4 9.6 10.9
EBIT, % 15.76 8.78 7.13 8.34 12.03 10.41 10.41 10.41 10.41 10.41
Total Cash 10.5 11.9 8.2 7.4 16.1 16.2 18.4 21.0 24.0 27.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 13.8 17.4 21.3 24.6 24.1
Account Receivables, % 42.64 48.73 51.22 51.21 43.96
Inventories 3.1 2.1 3.2 4.2 3.7 4.8 5.5 6.3 7.1 8.1
Inventories, % 9.5 5.91 7.63 8.78 6.78 7.72 7.72 7.72 7.72 7.72
Accounts Payable .6 .7 1.3 1.4 1.0 1.4 1.6 1.8 2.1 2.4
Accounts Payable, % 1.71 1.92 3.03 2.85 1.85 2.27 2.27 2.27 2.27 2.27
Capital Expenditure -1.0 -.4 -1.5 -1.7 -.4 -1.5 -1.7 -2.0 -2.3 -2.6
Capital Expenditure, % -3.01 -1.25 -3.66 -3.57 -0.72191 -2.44 -2.44 -2.44 -2.44 -2.44
Tax Rate, % 26.81 26.81 26.81 26.81 26.81 26.81 26.81 26.81 26.81 26.81
EBITAT 4.1 2.3 2.3 3.1 4.8 5.0 5.6 6.4 7.3 8.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -12.5 .0 -3.0 -2.2 6.0 -1.8 .5 .5 .6 .7
WACC, % 5.61 5.61 5.61 5.61 5.61 5.61 5.61 5.61 5.61 5.61
PV UFCF
SUM PV UFCF .2
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 1
Terminal Value 45
Present Terminal Value 35
Enterprise Value 35
Net Debt -16
Equity Value 51
Diluted Shares Outstanding, MM 9
Equity Value Per Share 5.73

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real ELMD financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Quickly observe the effect of your inputs on Electromed’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Customizable Financial Inputs: Adjust essential metrics such as revenue growth, EBITDA %, and capital investments.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics.
  • High-Precision Accuracy: Leverages Electromed's (ELMD) actual financial data for credible valuation results.
  • Seamless Scenario Analysis: Easily evaluate various assumptions and analyze different outcomes.
  • Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Electromed, Inc.'s (ELMD) preloaded data.
  • 2. Modify Assumptions: Adjust critical inputs such as growth rates, WACC, and capital expenditures.
  • 3. See Results Immediately: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
  • 5. Present with Assurance: Deliver professional valuation insights to enhance your decision-making process.

Why Choose Electromed, Inc. (ELMD) Calculator?

  • All-in-One Solution: Features DCF, WACC, and financial ratio analyses tailored for Electromed, Inc. (ELMD).
  • Flexible Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes Electromed, Inc. (ELMD)’s intrinsic value and Net Present Value.
  • Preloaded Information: Access to historical and projected data for precise evaluations.
  • Expert-Grade Tool: Perfect for financial analysts, investors, and business consultants focused on Electromed, Inc. (ELMD).

Who Should Use This Product?

  • Investors: Assess Electromed, Inc.'s (ELMD) market position before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and evaluate financial forecasts.
  • Startup Founders: Understand the valuation strategies of established companies like Electromed, Inc. (ELMD).
  • Consultants: Provide comprehensive valuation analyses for clients in the healthcare sector.
  • Students and Educators: Utilize current data to explore and teach valuation principles in a practical context.

What the Template Contains

  • Historical Data: Includes Electromed, Inc. (ELMD)’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Electromed, Inc. (ELMD)’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Electromed, Inc. (ELMD)’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.